Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

HLN – Haleon plcHLN

Haleon plc
HLN
$9.12
Name : Haleon plc
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $40,262,004,736.00
EPSttm : 0.49
finviz dynamic chart for HLN
Haleon plc
$9.12
2.59%
$0.23
HLN — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

0.34

Margin Of Safety %

Put/Call OI Ratio

0.16

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

9.12

Target Price

11.3

Analyst Recom

1.94

Performance Q

-10.32

Upside

18.2%

Beta

0.13

Ticker: HLN




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-11HLN8.980.090.823073
2026-05-12HLN9.10.090.133084
2026-05-13HLN9.020.098.003086
2026-05-14HLN8.920.090.283095
2026-05-15HLN8.950.090.643165
2026-05-18HLN9.160.280.00945
2026-05-19HLN9.20.260.00985
2026-05-20HLN9.270.260.02988
2026-05-21HLN9.330.250.001023
2026-05-22HLN9.30.250.031035
2026-05-26HLN9.240.240.001062
2026-05-27HLN9.310.240.001063
2026-05-28HLN9.220.240.001063
2026-05-29HLN9.060.24999.991068
2026-06-02HLN8.70.250.001092
2026-06-03HLN8.720.258.501093
2026-06-04HLN8.980.240.001089
2026-06-05HLN9.110.240.071092
2026-06-08HLN8.90.210.011217
2026-06-09HLN9.120.160.201552
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-11HLN8.98- - -
2026-05-12HLN9.10- - -
2026-05-13HLN9.02- - -
2026-05-14HLN8.91- - -
2026-05-15HLN8.95- - -
2026-05-18HLN9.16- - -
2026-05-19HLN9.19- - -
2026-05-20HLN9.28- - -
2026-05-21HLN9.32- - -
2026-05-22HLN9.29- - -
2026-05-26HLN9.24- - -
2026-05-27HLN9.32- - -
2026-05-28HLN9.22- - -
2026-05-29HLN9.06- - -
2026-06-01HLN8.83- - -
2026-06-02HLN8.72- - -
2026-06-03HLN8.72- - -
2026-06-04HLN8.98- - -
2026-06-05HLN9.10- - -
2026-06-08HLN8.90- - -
2026-06-09HLN9.12- - -
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-11HLN01.110.28
2026-05-12HLN01.110.34
2026-05-13HLN01.110.34
2026-05-14HLN01.110.34
2026-05-15HLN01.110.34
2026-05-18HLN01.370.34
2026-05-19HLN01.370.34
2026-05-20HLN01.370.34
2026-05-21HLN01.370.34
2026-05-22HLN01.370.34
2026-05-26HLN00.680.34
2026-05-27HLN00.680.34
2026-05-28HLN00.680.34
2026-05-29HLN00.680.34
2026-06-02HLN0-8.780.34
2026-06-03HLN0-8.780.34
2026-06-04HLN0-8.780.34
2026-06-05HLN0-8.780.34
2026-06-08HLN0-8.840.34
2026-06-09HLN0-8.840.34
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-8.84

Beta

0.13

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

21

Sentiment Score

25

Actual DrawDown %

20.1

Max Drawdown 5-Year %

Target Price

11.3

P/E

18.72

Forward P/E

14.98

PEG

1.59

P/S

2.77

P/B

1.84

P/Free Cash Flow

14.95

EPS

0.49

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

15.12

Relative Volume

1.07

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

HLN Healthcare
$9.12
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
2/20
Pullback
13/25
Volume
4/15
Valuation
15/20
TP/AR
1/10
Options
7/10
RSI
49.1
Range 1M
62.6%
Sup Dist
3.1%
🚀
Momentum Growth
Ride accelerating trends
N/A
28 /100
WEAK
Momentum
1/25
Growth
16/30
Estimates
0/20
Inst/Vol
1/15
Options
10/10
EPS Yr
9.3%
EPS NY
9.5%
52W%
17.5%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟡 HOLD +25% upside
Quality
7/30
Valuation
6/30
Growth
11/25
Stability
4/10
LT Trend
1/5
Upside
+25%
Haleon plc
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 24535
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
HLN

Latest News

Caricamento notizie per HLN
stock quote shares HLN – Haleon plcHLN Stock Price stock today
news today HLN – Haleon plcHLN stock forecast ,stock prediction 2023 2024 2025
marketwatch HLN – Haleon plcHLN yahoo finance google finance
stock history HLN – Haleon plcHLN invest stock market
stock prices HLN premarket after hours
ticker HLN fair value insiders trading